Want to see AU:GGR full AI Analyst Report?
Reckon Health Care Holdings Ltd (GGR) Ratios
Reckon Health Care Holdings Ltd Ratios
AU:GGR's free cash flow for Q4 2025 was $-635.68K. For the 2025 fiscal year, AU:GGR's free cash flow was decreased by $-1.41K and operating cash flow was $-634.27K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Dec 24 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.27 | 0.26 | 0.06 | 2.22 | 9.95 |
| Quick Ratio | 7.27 | 0.26 | 0.06 | 2.22 | 9.95 |
| Cash Ratio | 6.86 | 0.19 | 0.00 | 0.92 | 9.00 |
| Solvency Ratio | -4.31 | -0.24 | -0.49 | -6.60 | -11.88 |
| Operating Cash Flow Ratio | -4.08 | -0.35 | -0.55 | -5.28 | -9.71 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -1.24 | -1.48 | 0.00 | 0.00 |
| Net Current Asset Value | $ 3.25M | $ -1.02M | $ -634.58K | $ 250.11K | $ 1.07M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.15 | 0.11 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.33 | 0.15 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.25 | 0.13 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.07 | 2.17 | 1.41 | 1.07 | 1.03 |
| Debt Service Coverage Ratio | -735.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -736.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.69 | 0.00 | 0.00 | 0.16 | 0.86 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -16154.16% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -15699.20% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -10654.44% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -18199.63% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -18199.63% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -18199.63% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 106.08% | 136.71% | 170.33% | 170.82% | 185.29% |
| Return on Assets (ROA) | -26.33% | -70.84% | -49.37% | -46.96% | -40.22% |
| Return on Equity (ROE) | -28.05% | -153.93% | -69.41% | -50.46% | -41.56% |
| Return on Capital Employed (ROCE) | -26.44% | -112.60% | -40.75% | -29.54% | -22.43% |
| Return on Invested Capital (ROIC) | -26.44% | -84.55% | -35.39% | -29.54% | -22.20% |
| Return on Tangible Assets | -26.33% | -70.84% | -49.37% | -46.96% | -40.22% |
| Earnings Yield | -11.30% | -10.95% | -6.84% | -8.16% | -9.08% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Cash Conversion Cycle | -144279.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 144279.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.01 | -0.00 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | -280.73 | -7.56 | -3.52 | -5.42 | -2.08 |
| Capital Expenditure Coverage Ratio | -280.73 | -7.56 | -3.52 | -5.42 | -2.08 |
| Operating Cash Flow Coverage Ratio | 0.00 | -1.24 | -1.48 | 0.00 | -30.86 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -142.04 | 0.00 |
| Free Cash Flow Yield | -10.73% | -3.31% | -2.83% | -7.54% | -10.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.84 | -9.18 | -14.62 | -12.25 | -11.01 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 2230.35 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.48 | 14.06 | 10.15 | 6.18 | 4.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.32 | -30.23 | -35.31 | -13.26 | -9.54 |
| Price-to-Operating Cash Flow Ratio | -9.35 | -34.23 | -45.34 | -15.70 | -14.13 |
| Price-to-Earnings Growth (PEG) Ratio | 1.02 | -0.15 | 0.87 | 1.18 | 1.02 |
| Enterprise Value Multiple | -7.70 | 0.00 | 0.00 | -14.05 | -12.72 |
| Enterprise Value | 16.21M | 16.65M | 17.20M | 16.84M | 15.32M |
| EV to EBITDA | -7.70 | 0.00 | 0.00 | -14.05 | -12.72 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 2205.53 | 0.00 |
| EV to Free Cash Flow | -7.64 | -30.47 | -35.83 | -13.11 | -8.94 |
| EV to Operating Cash Flow | -7.67 | -34.50 | -46.02 | -15.53 | -13.24 |
| Tangible Book Value Per Share | 0.07 | 0.01 | 0.02 | 0.03 | 0.04 |
| Shareholders’ Equity Per Share | 0.07 | 0.01 | 0.02 | 0.03 | 0.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.06 | 1.22 | 1.41 | 1.13 | 1.17 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 88.81 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.95 | 0.27 | 0.32 | 0.78 | 0.78 |
Currency in AUD